Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep323 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Ketogenic diet and Glucagon-like peptide 1 (GLP1) receptor agonists for obesity: our experience

Pisocri Elisa , Cimorelli Manuela , Cerutti Nadia

Background & aims: it is now known that the benefits due to weight loss are therefore attenuated by the recovery of body weight. Two therapeutic options facilitate the maintenance of weight loss at a distance: very low caloric ketogenic diet (VLCKD) and medications; the recent literature also shows how much the recovery of weight loss is significantly lower in subjects treated with medications for obesity than in them who have taken a VLCKD or low calorie diet. The aim of ...